Latest News and Press Releases
Want to stay updated on the latest news?
-
Orkla ASA has acquired 957,732 shares in Scandinavian Property Development. After this transaction Orkla owns 8,954,880 shares in Scandinavian Property Development, which represents 11.19 % of the...
-
On January 30, 2008, shareholder Haralds Āboliņš sold 4.878% of his shares to “HRG ieguldījumi, Ltd.” As a result of this transaction, “HRG ieguldījumi, Ltd.” now owns 9.756% of JSC “Reģionālā...
-
Nõukogu otsused: 1.Paldiski Lõunasadma uute kaide rajamisse investeeritakse 355 miljonit EEK. 2.Vanasadamas teostatakse uute laevaliinide vastuvõtmisega seotud parenduslikud investeeringud...
-
Vandaag is mijn laatste dag bij Koninklijke Ahold. Het was een grote eer en ervaring om dit bedrijf en het bestuur te ondersteunen in de afgelopen vijf jaar. Ik begin voor mezelf en leg mij toe...
-
Today is my last day at Royal Ahold. It has been a great honour and experience to support this company and its executive board in the last five years. Currently I am starting my own business outside...
-
SAN JOSE, CA--(Marketwire - February 5, 2008) - Cisco® (NASDAQ: CSCO) today announced key findings from its annual global study on remote workers' security awareness and online behavior,...
-
SAN JOSE, CA--(Marketwire - February 5, 2008) - Cisco (NASDAQ: CSCO) has scheduled a conference call on Wednesday, February 6, 2008 at 1:30 PM (PT) to announce its second quarter fiscal year 2008...
-
NEW YORK, Feb. 5, 2008 (PRIME NEWSWIRE) -- CAST, the worldwide leader in Application Intelligence, today announced that their fiscal year 2007 revenue increased by 34%, with software revenue growth of...
-
REDONDO BEACH, Calif., Feb. 5, 2008 (PRIME NEWSWIRE) -- Northrop Grumman Corporation (NYSE:NOC) has received a Missile Defense Agency (MDA) contract for the second phase of a five-and-a-half year...
-
SCOTTSDALE, Ariz., Feb. 5, 2008 (PRIME NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the Merrill Lynch 19th Annual Global Pharmaceutical, Biotechnology...